With Strong Anti-Inflammatory Candidate In Hand, Abivax Execs Carve A Path Forward
With a strong late-stage anti-inflammatory molecule in its pipeline, the challenge for Abivax is to garner the funds to take its obefazimod program forward. To that end, the company is continuing to do a major overhaul of personnel and is sharpening its corporate vision.